Anthem, Cigna merger squabbles could delay antitrust approval: WSJ

Go back to Anthem, Cigna merger squabbles could delay antitrust approval: WSJ

Anthem (ANTM): Time To Consider It As A Standalone Company - FBR (CI)

May 23, 2016 8:57 AM EDT

FBR Capital analyst, Steven Halper, views the Anthem (NYSE: ANTM)/Cigna (NYSE: CI) merger as less likely to close and thinks investors need to view the companies on their individual merits.

Over the weekend, the Wall Street Journal reported that discord exists between Anthem and... More